Past Newsletters

How We’re Fighting Surprise Medical Billing
Healthcare In Transition | Apr. 18, 2019 | Healthcare

April 18, 2019 The Council has joined over 30 other employment-based trade groups to provide two letters on the issue of surprise medical billing to House leadership, and the chair

The Latest on Healthcare from our Government Affairs Duo
Healthcare In Transition, Video | Apr. 18, 2019 | ACA, Association health plans, Healthcare, Medicare, Prescription Drug Pricing

April 18, 2019 Joel Wood, SVP, Government Affairs and Joel Kopperud, VP, Government Affairs, give us the lowdown on AHPs, the ACA, Medicare for All and drug pricing—and what we can

An Update on Association Health Plans
Healthcare In Transition | Apr. 18, 2019 | Association health plans, Healthcare

April 18, 2019 In response to a federal district court decision to set aside portions of the DOL’s Association Health Plan (AHP) rule, a group of Republican senators, led by

Webinar: Tools You Can Use to Dig into National Prescription Drug Pricing
Council Brief, Healthcare In Transition, Webinar | Mar. 21, 2019 | Healthcare, Healthcare costs, Healthcare data, Healthcare data & technology, PBM, Pharmacy supply chain, Prescription Drug Pricing, Pricing transparency

March 21, 2019 The Council’s Katie Oberkircher spoke with Eric Pachman and Antonio Ciaccia, co-founders of 46Brooklyn—a prescription drug research firm—to demonstrate how to use the tools they’ve created to

What We’re Watching on Capitol Hill
Healthcare In Transition | Mar. 21, 2019 | Access to Care, Government Affairs, Healthcare costs, Healthcare reform, Individual insurance market, Payment reform, Prescription Drug Pricing, Pricing transparency, Reinsurance, Surprise Medical Billing

March 21, 2019 Our Government Affairs team is monitoring bills and action items that would affect the insurance industry. Here’s what we’re focusing on as of late: The “Short on

Federal Drug Pricing Legislation Tracker as of 3/15/19
Council Brief, Healthcare In Transition | Mar. 15, 2019 | Government Affairs, Healthcare costs, Healthcare reform, Payment reform, Prescription Drug Pricing, Pricing transparency

March 15, 2019 The Council’s expert legal team at Steptoe & Johnson created a chart to show the broad landscape of drug pricing legislation in Congress. The chart is updated

Unable to join us for the Legislative & Working Groups Summit?
Healthcare In Transition | Feb. 21, 2019 | Government Affairs, Healthcare costs, Healthcare reform, Payment reform, Pharmacy supply chain, Prescription Drug Pricing, Single Payer

The main topic of discussion? How to demonstrate the effectiveness of the employer-sponsored insurance system within a growing national dialogue on government-run healthcare.